Enterprise-grade contract research frameworks designed for full regulatory dossier submission and robust commercial transfer.
In vivo pharmacodynamics, dose-response kinetics & systemic toxicology verification.
Learn More
Cellular molecular pathways, enzymatic inhibition & phenotypic bioactivity screens.
Learn More
Human safety validation, GCP-compliant clinical trials & functional label claim substantiation.
Learn More
Origin fingerprinting, harvest lifecycle mapping & phytochemical concentration auditing.
Learn More
USP/EP compliant HPLC, GC, LC-MS validation and chromatographic fingerprinting.
Learn More
High-throughput fractionation, target isolation & botanical constituent identification.
Learn More
Purification optimization for alkaloids, polyphenols, saponins, and polysaccharides.
Learn More
Agronomic chemistry metrics, solvent matrix evaluation & extraction yield modeling.
Learn MoreThe global natural medicine landscape is migrating from commoditized dry extracts to molecularly standardized, clinically verified active substances.
Global regulatory bodies (FDA, EFSA, NMPA) and discerning modern consumers reject unverified historical anecdotes. Procurement teams now mandate quantifiable mechanisms of action, cell-line assays, and placebo-controlled trials to defend structural/functional label claims against legal scrutiny.
Supply chain adulteration remains the central vulnerability of phytomedicines. Modern R&D partners must provide high-resolution chromatographic fingerprints (HPTLC/HPLC) to prove unadulterated botanical lineages across fluctuating geographical environments and seasonal variations.
Siloed operational workflows—where basic research occurs in independent Western institutes while extraction happens overseas—create severe tech-transfer frictions. Tier-1 life sciences organizations now demand unified CRO-CDMO architectures where discovery data directly informs pilot-scale downstream refining.
Combining millennia of ethnobotanical records with cutting-edge separation automation, digital extraction loops, and rapid industrialization velocity.
Closed-loop, continuous countercurrent extraction trains equipped with SCADA automation and macroporous resin chromatography to deliver batch purity standard deviations under 0.8%.
Strict structural isolation between upstream proprietary bioassay discovery and toll manufacturing, enforced via bilateral NDAs and blind coded batch tracing to ensure absolute formula defense.
Generation of comprehensive CMC (Chemistry, Manufacturing, and Controls) packages, residual solvent validation, impurity profiling, and stability studies matching ICH guidelines.
Shorten the critical pathway from benchtop active fraction identification to 10-ton industrial pilot synthesis by 45%, bypassing fragmented intermediate vendor logistics.
A proven track record supporting premier international brands, state-level TCM hospitals, and top-tier pharmaceutical entities.
Whether engaging us for an isolated analytical protocol or comprehensive turnkey pipeline commercialization, every stage concludes with an auditable data deliverable.
Phytochemical library fractionation targeting alkaloids, saponins, polyphenols, and polysaccharides to locate peak molecular affinities.
Multi-origin harvesting matrices to quantify chemotype variations, terroir impacts, and seasonal compound concentration spikes.
Validation of HPTLC, HPLC, GC-MS, and chromatographic fingerprint standard operating procedures for robust QA/QC releases.
Engineering pilot parameters: solvent polarity ratios, thermal residence times, membrane microfiltration, and vacuum drying yields.
Overcoming organoleptic bitterness, active oxidation, and poor dissolution profiles through microencapsulation and granulate science.
Establishing safety thresholds via LD50 acute toxicity, repeated 90-day sub-chronic assays, and Ames genotoxicity protocols.
Target-specific cell culture assays validating anti-inflammatory (TNF-α, IL-6), antioxidant, and metabolic enzyme pathways.
Establishing functional efficacy and in vivo pharmacokinetic biodistribution inside validated rodent physiological models.
GCP-compliant human safety evaluation, double-blind placebo testing, and statistical dossiers for regulatory drug approvals.
Decoding complex synergistic poly-herbal interactions using computational systems biology and modern pharmacology.
Commercial batch production of concentrated standardized liquids, microfine extract powders, pastes, and concentrated volatile oils.
Turnkey cGMP manufacturing of ready-to-market oral liquids, softgels, hard capsules, functional tablets, and effervescent granules.
Translating analytical milestones into high-margin end consumer products tailored to distinct regional compliance environments.
Engineered for brands targeting North American (DSHEA) and European (EFSA) markets requiring non-GMO, clean-label, bioavailable active concentrates. Delivered as free-flowing granules, water-dispersible powders, and standardized botanical actives that resist moisture degradation.
Tailored for biopharmaceutical developers requiring rigorous botanical drug development protocols. Full CMC data dossiers, stability studies under ICH conditions, GLP-compliant preclinical animal studies, and Phase I–IV clinical validation to withstand international regulatory scrutiny.
Purified natural active fractions optimized for topical transdermal delivery. Supported by in vitro human keratinocyte (HaCaT) and fibroblast protection assays proving anti-aging, hyperpigmentation reduction, barrier restoration, and anti-inflammatory efficacy without cytotoxicity.
Our collaborative R&D footprint powers national research projects, drug industrialization, and hospital preparation formulations.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Group
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Humanwell Group
Apeloa Pharma
Kangmei Pharma
Shuguang Hospital
Xiangya Second Hospital
Crucial commercial, regulatory, and procedural considerations for life sciences executives evaluating an outsourced Chinese R&D partner.
We operate on a legally bound entrusted contract research framework. All intellectual property, process parameters, extraction kinetics, and novel assays remain the client's sole asset. Internal laboratory information management systems (LIMS) segregate project data, and pilot manufacturing operations utilize blinded tracking codes.
Yes. MedGence's integrated model ensures that analytical protocols and solvent purification processes established at our Changsha research center transfer seamlessly to our directly managed pilot plants and collaborative cGMP facilities, eliminating tech-transfer failure risks.
We deploy high-performance thin-layer chromatography (HPTLC) for species identity fingerprinting, reverse-phase HPLC with diode-array detection (DAD) and evaporative light scattering (ELSD) for quantitative assay validation, and GC-MS for residual solvent and volatile terpene auditing.
Finished dosage formulations cover two-piece hard shell vegetable capsules, softgels with lipid suspensions, high-pressure direct-compression tablets, enteric-coated formats, functional oral liquid ampoules, and micro-granulated effervescent drink sachets.
Accelerate your next product iteration with our validated research methodologies and standardized raw material assets.
Preclinical protocol architecture, LD50 evaluation & rodent physiological screening.
Request Study Scope
Phenotypic screening, target enzyme kinetics, and cell viability assays.
Request Study Scope
Human clinical evaluation protocol design and full GCP documentation.
Request Study Scope
Origin fingerprinting, harvest seasonal optimization & density verification.
Request Study Scope
Validation of HPLC, HPTLC, and chromatographic fingerprint standard protocols.
Request Study Scope
High-throughput fractionation and bioactive component validation pipelines.
Request Study Scope
Industrial-scale supply of standardized powders, resin extracts, and volatile oils.
Request Study Scope
Full-line contract manufacturing of capsules, oral liquids, tablets, and drink granulates.
Request Study ScopeSubmit your target indication, compound requirement, or formulation specification to connect directly with our scientific committee in Changsha, Hunan.
